About Programs Patients Sustainability Collaborations Investors Careers Be the The expertise to create cures and life-changing treatments Assembly Bio is passionately applying scientific ingenuity and a deep knowledge of virology to find a cure for hepatitis B (HBV) infection, one of the world’s most prevalent and devastating infectious diseases. Be a part of our ambitious and caring life’s work. Together, we have the potential to change lives. Explore more > In the News November 12, 2021 Assembly Biosciences Presents New Data at AASLD The Liver Meeting™ Highlighting the Progress of its HBV Core Inhibitor Portfolio “As a resident in Anesthesiology and Intensive Care, I’ve seen patients die of the consequences of hepatitis B, and I can see that it has a devasting impact on people in every country around the world. Now is the time to cure hepatitis B and save over 800,000 unnecessary deaths every year. I am grateful for the support and partnership of Assembly Bio in our shared goal of eradicating hepatitis B once and for all.” — Dr Hélène Drouin, Resident in Anesthesiology and Intensive Care, future Mount Everest climber “It’s time to end the deadly Hepatitis B virus that has killed more than 800,000 people a year, including my own family members. I’m encouraged by the efforts of Assembly Bio to develop better treatments that could lead to a cure.” — Alan Wang, Emmy award-winning television news anchor. Infected at birth with chronic Hepatitis B. 1 2 Contact Us 833.509.4583 info@assemblybio.com LinkedIn About Programs Patients Sustainability Collaborations Investors Careers © 2021 Assembly Biosciences, Inc.

Skip to main navigation About Programs Patients Sustainability Collaborations Investors Careers On the Financials & Filings Quarterly Results SEC Filings Annual Reports Financials & Filings Annual Reports Documents 2020 Annual Report 2.97 MB 2019 Annual Report 1.18 MB Proxy Statements Filing date Form View Apr 7, 2021 DEF 14A ASMB - Proxy Statement FINAL.pdf 0001564590-21-018007.rtf 0001564590-21-018007.xls View HTML Apr 7, 2021 DEFA14A 0001564590-21-018015.pdf 0001564590-21-018015.rtf 0001564590-21-018015.xls View HTML Form 10-K Filing date View Feb 25, 2021 0001564590-21-008878.pdf 0001564590-21-008878.rtf 0001564590-21-008878.xls View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Mar 4, 2020 0001564590-20-008696.pdf 0001564590-20-008696.rtf 0001564590-20-008696.xls View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Form 10-Q Filing date View Nov 4, 2021 0001564590-21-054499.pdf 0001564590-21-054499.rtf 0001564590-21-054499.xls View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Aug 5, 2021 0001564590-21-041680.pdf 0001564590-21-041680.rtf 0001564590-21-041680.xls View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Shareholder Tools Search Investors Contact Us 833.509.4583 info@assemblybio.com LinkedIn About Programs Patients Collaborations Investors Careers © 2021 Assembly Biosciences, Inc.